Early ideas to improve the delivery of nucleic acid therapeutics
|קרן||UK Medical Research Council (MRC)|
|סוג||Research Grants, Partnership Activities|
|פקולטה||Engineering, Exact Sciences, Life Sciences, Medicine|
This funding opportunity will support a consortium to tackle major barriers to safe and effective NAT delivery through the development of novel technologies, platforms and resources. To solve these challenges, new approaches could arise from any scientific discipline or therapeutic modality. Proposals must articulate a substantial, ambitious programme of work with clear potential to catalyse a step change in the delivery of NATs.
- PI must be from a UK institution (academic or SME)
- Min. 2 partners one must be a commercial entity
It is expected that one consortium will be funded under this Call.
Funding: £6,000,000 total
Duration: 3 years
Research Authority due date: 30.12.21
Expression of interest (required) due date: 6.1.22
Full proposal due date: April 2022
|עדכון אחרון||עדכון אחרון: 09/11/2021|